Dyne Therapeutics, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US26818M1080
USD
20.87
1.07 (5.4%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
4D Molecular Therapeutics, Inc.
Alpine Immune Sciences, Inc.
Alector, Inc.
Avid Bioservices, Inc.
Entrada Therapeutics, Inc.
Dyne Therapeutics, Inc.
Vera Therapeutics, Inc.
Enliven Therapeutics, Inc.
Allogene Therapeutics, Inc.
Anavex Life Sciences Corp.
HilleVax, Inc.

Why is Dyne Therapeutics, Inc. ?

Icon
Unrated Stock - No Analysis Available
stock-recommendationReal-Time Research Report

Verdict Report

Icon
No Data Found

Is Dyne Therapeutics, Inc. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Dyne Therapeutics, Inc.
102.23%
-0.42
80.91%
S&P 500
25.22%
1.91
13.23%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
-248.17%
EBIT to Interest (avg)
-251.07
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.01
Sales to Capital Employed (avg)
0
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.91
EV to EBIT
-4.00
EV to EBITDA
-4.02
EV to Capital Employed
121.04
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-3023.86%
ROE (Latest)
-45.90%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

8What is working for the Company
NET PROFIT(HY)

Higher at USD -232.81 MM

ROCE(HY)

Highest at -58.89%

RAW MATERIAL COST(Y)

Fallen by 0% (YoY

CASH AND EQV(HY)

Highest at USD 2,082.72 MM

EPS(Q)

Highest at USD -0.73

-13What is not working for the Company
OPERATING CASH FLOW(Y)

Lowest at USD -442.23 MM

INTEREST(Q)

Highest at USD 4.2 MM

OPERATING PROFIT(Q)

Lowest at USD -124.73 MM

PRE-TAX PROFIT(Q)

Lowest at USD -120.85 MM

NET PROFIT(Q)

Lowest at USD -120.85 MM

Here's what is working for Dyne Therapeutics, Inc.

EPS
Highest at USD -0.73
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (USD)

Cash and Eqv
Highest at USD 2,082.72 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Raw Material Cost
Fallen by 0% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Dyne Therapeutics, Inc.

Operating Cash Flow
Lowest at USD -442.23 MM and Fallen
In each year in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (USD MM)

Interest
At USD 4.2 MM has Grown at 31.56%
period on period (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Interest
Highest at USD 4.2 MM
in the last five periods and Increased by 31.56% (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Operating Profit
Lowest at USD -124.73 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (USD MM)

Pre-Tax Profit
Lowest at USD -120.85 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (USD MM)

Net Profit
Lowest at USD -120.85 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is negative

Net Profit (USD MM)